FINWIRES · TerminalLIVE
FINWIRES

Sector Update: Health Care Stocks Softer Friday Afternoon

By

Health care stocks fell Friday afternoon with the NYSE Health Care Index easing 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.3%.

The iShares Biotechnology ETF (IBB) shed 0.7%.

In corporate news, Moderna (MRNA) affirmed its 2026 revenue growth outlook and reported better-than-expected Q1 results amid higher COVID vaccine sales. The stock still declined 2.9%.

Amgen's (AMGN) Q1 EPS beat was primarily driven by lower administrative costs and taxes, Morgan Stanley said. Amgen shares fell 5.6%.

Novo Nordisk (NVO) rebranded its oral semaglutide medication for type 2 diabetes as Ozempic. It was formerly marketed as Rybelsus. Novo shares gained 3.2%.

Related Articles

Sectors

Market Chatter: Trump Administration Authorizes New pipeline From Canada to U.S.

U.S. President Donald Trump on Thursday signed an order authorizing the Bridger Pipeline's proposed project to transport Canadian crude from the U.S.-Canada border to Wyoming, CTV News reported.Bridger Pipeline's project would have the capacity to move more than 1 million barrels of oil per day, according to the company. If built and connected, analysts told Reuters it could increase Canada's crude exports to the U.S. by more than 12%.(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$CLM6$LCOM6$USO
Sectors

Sector Update: Energy Stocks Rise Late Afternoon

Energy stocks were higher late Thursday afternoon, with the NYSE Energy Sector Index gaining 1% and the State Street Energy Select Sector SPDR ETF (XLE) up 0.8%.The Philadelphia Oil Service Sector Index advanced 0.4%, and the Dow Jones US Utilities Index climbed 2.4%.West Texas Intermediate crude oil fell 2% to $104.75 a barrel, and global benchmark Brent dropped 3.4% to $114.01 a barrel. Henry Hub natural gas futures rose 4.4% to $2.76 per 1 million BTU.In sector news, US natural gas stocks rose by 79 billion cubic feet in the week ended April 24, slower than the 83 billion increase expected in a Bloomberg survey and following an increase of 103 billion cubic feet in the previous week.In corporate news, Southern (SO) shares climbed 2.6% after it reported Q1 adjusted EPS of $1.32, up from $1.23 a year ago. Analysts polled by FactSet expected $1.21.Apollo Global Management (APO), Blackstone (BX) and KKR (KKR) are among the final bidders for a major stake in Shell's (SHEL) LNG Canada project in a deal that could top $10 billion and reach as much as $15 billion, Reuters reported. Shell shares rose 2.1%.TotalEnergies (TTE) and partner Nextnorth have reached financial close and broke ground on a 440 MWp solar power plant in Ilagan, Philippines, the companies said. TotalEnergies shares added 1.4%.BP (BP) has signed an agreement with Venezuela to explore offshore natural gas, as the country's energy sector gathers momentum following the US capture of Nicolas Maduro in January, Bloomberg reported. BP shares were up 1.2%.

$BP$SHEL$SO$TTE
Sectors

Sector Update: Health Care Stocks Gain Late Afternoon

Health care stocks rose late Thursday afternoon with the NYSE Health Care Index climbing 2.6% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 2.3%.The iShares Biotechnology ETF (IBB) advanced 1.9%.In corporate news, UniQure (QURE) shares jumped past 16% after the company said it plans to submit a UK marketing authorization application in Q3 for AMT-130 to treat Huntington's disease.Axsome Therapeutics (AXSM) shares surged 12% after it said the US Food and Drug Administration approved Auvelity to treat agitation associated with Alzheimer's disease dementia.Eli Lilly (LLY) raised its full-year outlook and reported Q1 results above market estimates as sales of Mounjaro more than doubled. Lilly shares jumped past 10%.The US Food and Drug Administration is proposing to exclude tirzepatide, semaglutide and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound the drugs from bulk substances. Eli Lilly makes tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management. Novo Nordisk (NVO) makes semaglutide, marketed as Ozempic for type 2 diabetes and Wegovy for chronic weight management, and liraglutide, under the brand name Victoza for type 2 diabetes and Saxenda for chronic weight management. Novo shares rose past 5%.

$AXSM$LLY$NVO$QURE